Emergent BioSolutions, U.S. Department of Health and Human Services infectious news

HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded Emergent a contract worth up to $186.6 million to develop a recombinant protective antigen (rPA) anthrax vaccine. The cont...